{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T13:25:47Z","timestamp":1648992347847},"reference-count":5,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.leukres.2012.05.024","type":"journal-article","created":{"date-parts":[[2012,6,20]],"date-time":"2012-06-20T19:16:46Z","timestamp":1340219806000},"page":"1208-1209","source":"Crossref","is-referenced-by-count":1,"title":["Personalized strategies for CML patients considering discontinuation of tyrosine kinase inhibitors treatment"],"prefix":"10.1016","volume":"36","author":[{"given":"Fabio","family":"Stagno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Vigneri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Cupri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Stella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Di Raimondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2012.05.024_bib0005","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.leukres.2012.02.011","article-title":"Imatinib mesylate discontinuation in patients with chronic myeloid leukemia who have received front-line imatinib mesylate therapy and achieved complete molecular response","volume":"36","author":"Yhim","year":"2012","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2012.05.024_bib0010","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/S1470-2045(10)70233-3","article-title":"Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial","volume":"11","author":"Mahon","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.leukres.2012.05.024_bib0015","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S1470-2045(11)70017-1","article-title":"Imatinib discontinuation: realistic for patients with chronic myeloid leukaemia achieving complete molecular remission?","volume":"12","author":"Stagno","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.leukres.2012.05.024_bib0020","doi-asserted-by":"crossref","DOI":"10.1038\/leu.2012.104","article-title":"Standardized definitions of molecular response in chronic myeloid leukemia","author":"Cross","year":"2012","journal-title":"Leukemia."},{"key":"10.1016\/j.leukres.2012.05.024_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.leukres.2012.03.016","article-title":"Towards a need to a \u201cbiological Sokal risk\u201d in the era of tyrosine kinase inhibitors in choosing front-line therapy in chronic myeloid leukemia","author":"Stagno","year":"2012","journal-title":"Leuk Res"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212612002494?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212612002494?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,22]],"date-time":"2018-11-22T16:56:57Z","timestamp":1542905817000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212612002494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":5,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S0145212612002494"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2012.05.024","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}